Physician

Joseph W Ippolito, M.D.

According to 2025 Medicare claims, Joseph Ippolito, M.D. (NPI: 1306862792) practices family practice in the Twin Falls, ID market, with the plurality of this provider's patient population coming from Twin Falls, ID. This provider's primary affiliated billing organization is JOSEPH W IPPOLITO JR MD PLLC (NPI: 1154561116; TIN: 510479191) and primary practice location at 83301-5050. Ippolito is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Ippolito's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 211 traditional Medicare patients, billed 1,167 HCPCS/CPT codes, and received $85,980 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 13,725 prescription claims across 536 beneficiaries totaling $941,140 in drug costs, led by Eliquis (Apixaban). DME data shows 436 claims. Open Payments data shows 22 records totaling $386. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $581,367 to $941,140. For DME billing, reported payments moved sharply higher in recent years, from $24,824 to $38,170.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	298	1,828	$98,610
2016	291	1,776	$96,529
2017	289	1,815	$90,939
2018	287	1,869	$99,047
2019	288	1,662	$96,163
2020	283	1,596	$97,118
2021	248	1,425	$105,063
2022	238	1,281	$92,643
2023	230	1,221	$86,401
2024	211	1,167	$85,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	378	11,947	$581,367
2016	405	12,525	$592,840
2017	406	12,612	$708,128
2018	413	12,755	$708,219
2019	456	12,835	$730,414
2020	459	13,919	$809,325
2021	481	13,670	$801,550
2022	484	13,043	$913,190
2023	518	13,120	$994,003
2024	536	13,725	$941,140

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	40	463	$33,227
2016	44	432	$31,482
2017	21	322	$18,391
2018	34	336	$18,792
2019	64	478	$29,510
2020	104	595	$42,847
2021	104	483	$38,245
2022	62	405	$30,570
2023	105	493	$25,322
2024	73	436	$28,417

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	126	126	$126
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	28	32	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	162	443	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	184	$62
G0444	Annual depression screening, 5 to 15 minutes	126	126	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	158	6,291	$120,639
Jardiance	Empagliflozin	121	5,257	$97,455
Xarelto	Rivaroxaban	111	3,993	$70,431
Mounjaro	Tirzepatide	60	1,736	$63,881
Ozempic	Semaglutide	59	1,960	$62,879

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	16	$8,496
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	95	$6,444
A7031	Face mask interface, replacement for full face mask, each	N	N/R	24	$2,403
A7030	Full face mask used with positive airway pressure device, each	N	12	27	$2,201
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,674

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$386	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph W. Ippolito, M.D.?

Tedicare shows public-source Medicare data for Joseph W. Ippolito, M.D. (NPI 1306862792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph W. Ippolito, M.D. have ACO affiliation data?

Joseph W. Ippolito, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Joseph W. Ippolito, M.D.?

Joseph W. Ippolito, M.D. is linked to JOSEPH W IPPOLITO JR MD PLLC (billing NPI 1154561116) in the available physician profile data.

Does Joseph W. Ippolito, M.D. have Open Payments data?

Joseph W. Ippolito, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.